Caris Diagnostics/Molecular Profiling Institute
This article was originally published in The Gray Sheet
Executive Summary
Surgical pathology services provider Caris Diagnostics acquires molecular diagnostics firm Molecular Profiling Institute under a deal announced Dec. 6. Certified under the Clinical Laboratory Improvement Amendments, MPI is a specialty reference laboratory that provides prognostic testing services and resources for genomic and proteomic profiling to help guide physicians in the treatment of cancer and other diseases. The acquisition "demonstrates our commitment to deliver health improvement by advancing the commercialization of personalized medicine," states Caris' Chairman David Halbert